...
首页> 外文期刊>Current hypertension reports. >Neural Control of Non-vasomotor Organs in Hypertension
【24h】

Neural Control of Non-vasomotor Organs in Hypertension

机译:高血压非血管舒缩器官的神经控制

获取原文
获取原文并翻译 | 示例
           

摘要

Hypertension affects over 25 % of the population with the incidence continuing to rise, due in part to the growing obesity epidemic. Chronic elevations in sympathetic nerve activity (SNA) are a hallmark of the disease and contribute to elevations in blood pressure through influences on the vasculature, kidney, and heart (i.e., neurogenic hypertension). In this regard, a number of central nervous system mechanisms and neural pathways have emerged as crucial in chronically elevating SNA. However, it is important to consider that "sympathetic signatures" are present, with differential increases in SNA to regional organs that are dependent upon the disease progression. Here, we discuss recent findings on the central nervous system mechanisms and autonomic regulatory networks involved in neurogenic hypertension, in both non-obesity- and obesity-associated hypertension, with an emphasis on angiotensin-II, salt, oxidative and endoplasmic reticulum stress, inflammation, and the adipokine leptin.
机译:高血压影响了超过25%的人口,其发病率持续上升,部分原因是肥胖病流行。交感神经活动(SNA)的慢性升高是该疾病的标志,并通过影响脉管系统,肾脏和心脏(即神经源性高血压)而导致血压升高。在这方面,许多中枢神经系统机制和神经通路已成为慢性升高SNA的关键。但是,重要的是要考虑到存在“交感神经信号”,而依赖于疾病进展的区域器官的SNA差异增加。在这里,我们讨论了与非肥胖和肥胖相关的高血压中涉及神经源性高血压的中枢神经系统机制和自主调节网络的最新发现,重点是血管紧张素II,盐,氧化和内质网应激,炎症,以及脂肪因子瘦素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号